When was Valencell founded?

Valencell was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is Valencell located?

Valencell is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina.

How many employees does Valencell have?

As of Dec 31, 2022, Valencell has 34 employees, reflecting a 7% year-over-year growth in headcount.

Is Valencell a funded company?

Valencell is a funded company, having raised a total of $37.6M across 20 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 14, 2007.

When was the latest funding round of Valencell?

Valencell's latest funding was a $***** Series E round on Jan 28, 2020, with participation from 4 investors. Its primary sector is Sensors. In United States, the Sensors sector has seen $48.7M in funding in 2026 to date.

Where does Valencell rank among its competitors?

Valencell ranks 17th amongst 266 active competitors, of which 65 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Xsensio, which secured an undisclosed amount in Mar, 2026.

Who are the top competitors of Valencell?

Valencell's top competitors include Profusa, Epicore Biosystems and InvenSense. Among them, Xsensio secured the most recent funding round in March, 2026.

Valencell - 2026 Company Profile, Team, Funding & Competitors

Valencell is a series E company based in Raleigh (United States), founded in 2006 by Steven Leboeuf. It operates as a Developer of based medical sensors for monitoring body vitals. Valencell has raised $37.6M in funding from investors like Best Buy, True Ventures and TDF Ventures. The company has 266 active competitors, including 65 funded and 18 that have exited. Its top competitors include companies like Profusa, Epicore Biosystems and InvenSense.

Company Details

Developer of AI-based medical devices for monitoring body vitals. It offers the technology for monitoring blood pressure, heart rate, VO2 max, step count, and respiration rate. The company offers PPG sensors that can calibrate multiple health vitals of the body for the wearable and hearable industry.

Website: valencell.com
Social
Email ID: *****@valencell.com
Phone Number: +1 **********
Registered Address: Raleigh, North Carolina

Key Metrics

Founded Year

2006

Location

Raleigh, United States

Stage

Series E

Total Funding

$37.6M in 20 rounds

Latest Funding Round

Series E, Jan 28, 2020, $*****

Investors

Best Buy & 8 more

Ranked

17^th among 266 active competitors

Employee Count

34 as on Dec 31, 2022

Similar Companies

Profusa & 186 more

View Valencell's full profile

Valencell is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Valencell, Inc. CIN: 205493056 , United States, Active	Dec 26, 999	$1 - $1M (As on Nov 23, 2009)	33 (As on Dec 31, 2023)	-

Valencell has raised a total funding of $37.6M over 20 rounds. Its first funding round was on May 14, 2007. Its latest funding round was a Series E round on Jan 28, 2020 for $*****. 4 investors participated in its latest round. Valencell has 9 institutional investors.

Here is the list of recent funding rounds of Valencell:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 28, 2020	6164860	Series E	8721006	4843672	2671843	7875311
Jun 13, 2018	3145058	Series E	9385667	6526880	5279364	TDF Ventures & 1 more
Mar 09, 2016	4365202	Series D	4246477	1989190	GII	TDF Ventures

Access funding benchmarks and valuations. Sign up today!

View details of Valencell's funding rounds and investors

The founders of Valencell is Steven Leboeuf. Kent Novak is the CEO of Valencell.

Here are the details of Valencell's key team members:

Steven Leboeuf: President & Co-Founder of Valencell.
Kent Novak: CEO of Valencell.

View details of Valencell's Founder profiles and Board Members

Valencell's employee count trend

Valencell has 34 employees as of Dec 22. The total employee count is 6.0% more than what it was in Dec 21. Here is Valencell's employee count trend over the years:

Uncover Valencell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Valencell include Profusa, Epicore Biosystems and InvenSense. Here is the list of Top 10 competitors of Valencell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Profusa 2009, San Francisco (United States), Series C	Biochemical sensors for chronic disease management	$62.2M	Tasly, Nasdaq & 13 others	65/100
2nd	Epicore Biosystems 2017, Cambridge (United States), Series B	Developer of sweat-sensing wearables for real-time health monitoring	$43.9M	Pegasus Tech Ventures, Alumni Ventures & 7 others	62/100
3rd	InvenSense 2003, San Jose (United States), Acquired	MEMS and magnetic sensor solutions for consumer, industrial, and automotive applications	$38M	Sierra Ventures, Qualcomm Ventures & 9 others	61/100
4th	Xsensio 2014, Lausanne (Switzerland), Series A	Provider of wearable biosensors	$11.6M	DART Ventures, Mayo Clinic & 11 others	61/100
5th	Vivalink 2014, Campbell (United States), Seed	Provider of wearable sensors and digital health solutions for monitoring	$1.54M	Niterra, Lifeblood Capital & 4 others	59/100
6th	Vectorious Medical Tech 2011, Tel Aviv (Israel), Acquired	Implant for left-atrial monitoring	$14.3M	Broadview Ventures, GEOC & 12 others	58/100
7th	Laborie Medical 1967, Mississauga (Canada), Acquired	Provider of products for lower urinary tract dysfunctions in females	-	Investor, Audax Private Equity	57/100
8th	Vital Connect 2011, Campbell (United States), Series G	Developer of biosensor patch for body vitals monitoring	$240M	Ally Bridge Group, Revelation Partners & 9 others	56/100
9th	Diamond Kinetics 2012, Pittsburgh (United States), Series C	Provider of impact sensors and app for real time swing analytics	$39.6M	Elysian Park, SeventySix Capital & 3 others	56/100
10th	Microlife 1981, Taipei (Taiwan), Public	Portfolio of thermometers and blood pressure monitors	-	Morgan Stanley Private Equity Asia	56/100
17th	Valencell 2006, Raleigh (United States), Series E	Developer of based medical sensors for monitoring body vitals	$37.6M	TDF Ventures, True Ventures & 7 others	48/100